Company intelligence
ChromaGenix
Pioneering the new standard of chromatography.
About ChromaGenix
We help biopharma innovators overcome some of the most persistent challenges in drug development: how to purify complex biologics such as AAVs, mRNA, and viral vectors, more efficiently, consistently, and at scale. We specialize in developing synthetic affinity ligands and chromatography resins that are engineered for the production of advanced therapies. Whether you’re working on gene therapy, vaccines, or emerging modalities, ChromaGenix is committed to solving your critical downstream challenges, backed by a culture of innovation, integrity, and scientific rigor.
Verified activity
Signals from ChromaGenix
3 published signals
Products & Services
ChromaGenix is developing a new approach for HCP clearance that selectively retains persistent HCPs while allowing the target product to flow through unbound without an elution step.
Reported by ChromaGenix
Partnerships
ChromaGenix is partnering with Sunresin to expand access to AAV purification technologies across Asia.
Reported by ChromaGenix
Products & Services
ChromaGenix pairs its ligand discovery technology with commercial manufacturing capabilities to turn design flexibility into scalable purification solutions.
Reported by ChromaGenix